• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALLERGAN (COSTA RICA) NATRELLE TE SMOOTH 133S-FX-13-T; EXPANDER, SKIN, INFLATABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALLERGAN (COSTA RICA) NATRELLE TE SMOOTH 133S-FX-13-T; EXPANDER, SKIN, INFLATABLE Back to Search Results
Catalog Number 133S-FX-13-T
Medical Device Problem Code Patient-Device Incompatibility (2682)
Health Effect - Clinical Code Foreign Body Reaction (1868)
Date of Event 08/08/2023
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
A review of the device history record has been initiated.If any new, changed or corrected information is noted, a supplemental medwatch will be submitted.Further information from the reporter regarding event, product, or patient details has been requested.No additional information is available at this time.Reason for reoperation: inferior tab torn away from tissue expander and exposure.
 
Event or Problem Description
Allergan representative reported "inferior tab that was dislodged in the pocket of the patient and caused it to be exposed with a scab.Upon removal of the tissue expander it was identified that the inferior tab had torn away from tissue expander." tissue expander has been explanted and replaced.
 
Event or Problem Description
Allergan representative reported "inferior tab that was dislodged in the pocket of the patient and caused it to be exposed with a scab.Upon removal of the tissue expander it was identified that the inferior tab had torn away from tissue expander." tissue expander has been explanted and replaced.
 
Additional Manufacturer Narrative
Device evaluation: based on the device analysis grid, the assessments of the complaint are: ¿ exposure: unable to observe since it is not related to the device.¿ other-technical: observed 6 o¿clock position suture tab was separated from the device.Additional observations: ¿ the piece of suture tab is missing assessed as inconclusive.¿ total delamination of suture tab at the 6 o¿clock position assessed as adhesive failure.¿ observed an opening on radius assessed as surgical damage.¿ brown particles observed outside the device.No further actions are required as the device was implanted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NATRELLE TE SMOOTH 133S-FX-13-T
Common Device Name
EXPANDER, SKIN, INFLATABLE
Manufacturer (Section D)
ALLERGAN (COSTA RICA)
900 parkway global park
zona franca
Manufacturer (Section G)
ALLERGAN (COSTA RICA)
900 parkway global park
zona franca
Manufacturer Contact
terry ingram
12331-a riata trace parkway
building 3
austin, TX 78727
8479366324
MDR Report Key17659587
Report Number9617229-2023-14325
Device Sequence Number6207954
Product Code LCJ
UDI-Device Identifier10888628044036
UDI-Public10888628044036
Combination Product (Y/N)N
Initial Reporter CountryUS
PMA/510(K) Number
K182054
Number of Events Summarized1
Summary Report (Y/N)N
Device Explanted Year2023
Reporter Type Manufacturer
Report Source Other,Company Representative
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date (Section B) 11/03/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Catalogue Number133S-FX-13-T
Device Lot Number3598846
Was Device Available for Evaluation? Device Returned to Manufacturer
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 08/08/2023
Supplement Date Received by Manufacturer10/13/2023
Initial Report FDA Received Date08/31/2023
Supplement Report FDA Received Date11/03/2023
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured03/15/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient SexFemale
-
-